203 related articles for article (PubMed ID: 23407147)
1. [Diagnosis and treatment of the epithelial ovarian cancer at the West African Cancer Center of Dakar].
Dem A; Dieng MM; Ka S; Gaye PM; Diouf D; Gaye-Fall MC
Bull Cancer; 2013 Feb; 100(2):155-60. PubMed ID: 23407147
[TBL] [Abstract][Full Text] [Related]
2. [The results of ovarian cancer therapy in the Hungarian Centers in 2002-2003].
Pulay T; Baki M; Bodoky G; Dank M; Cseh J; Csejtei A; Csömör S; Erfán J; Esik O; Faluhelyi Z; Izsó J; Hernádi Z; Kammerer K; Magyar T; Mayer A; Megyery E; Moskovits K; Pécsi L; Pikó B; Pintér T; Ruzsa A; Szánthó A; Szántó I; Szántó J; Szucs M; Tálos Z; Thurzó L; Kásler M
Orv Hetil; 2006 Dec; 147(52):2493-500. PubMed ID: 17294573
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of long-term prognostic factors of epithelial ovarian cancer].
Li MD; Li YJ; Huang YW; Huang H
Ai Zheng; 2004 Nov; 23(11):1306-10. PubMed ID: 15522179
[TBL] [Abstract][Full Text] [Related]
4. Borderline ovarian tumours: clinical analysis of 38 cases.
Behtash N; Modares M; Abolhasani M; Ghaemmaghami F; Mousavi M; Yarandi F; Hanjani P
J Obstet Gynaecol; 2004 Feb; 24(2):157-60. PubMed ID: 14766453
[TBL] [Abstract][Full Text] [Related]
5. Ovarian surface epithelial neoplasms in the pediatric population: incidence, histologic subtype, and natural history.
Hazard FK; Longacre TA
Am J Surg Pathol; 2013 Apr; 37(4):548-53. PubMed ID: 23388124
[TBL] [Abstract][Full Text] [Related]
6. [Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence].
Tu H; Huang H; Huang QD; Li Z; Feng YL; Liu JH
Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):928-33. PubMed ID: 23324194
[TBL] [Abstract][Full Text] [Related]
7. [Treatment and prognostic factors of epithelial ovarian cancer].
Wei L; Qian H; Li W
Zhonghua Fu Chan Ke Za Zhi; 1997 Aug; 32(8):476-9. PubMed ID: 9639741
[TBL] [Abstract][Full Text] [Related]
8. [Prognosis and prognostic factor analysis epithelial ovarian cancer].
Wen H; Sun W; Guo Y
Zhonghua Fu Chan Ke Za Zhi; 1997 Mar; 32(3):159-62. PubMed ID: 9596891
[TBL] [Abstract][Full Text] [Related]
9. [Clinical characteristics and prognosis of epithelial ovarian cancer in young women].
Tang L; Zheng M; Xiong Y; Ding H; Liu FY
Ai Zheng; 2008 Sep; 27(9):951-5. PubMed ID: 18799034
[TBL] [Abstract][Full Text] [Related]
10. [Clinical characteristics of borderline ovarian tumors and stage I epithelial ovarian cancer: an analysis of 143 cases].
Zhao Y; Wang Y; Shen Dh; Song Rn; Xu Q; Li Y; Cui H; Tang J; Wei Lh
Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Feb; 43(1):123-8. PubMed ID: 21321635
[TBL] [Abstract][Full Text] [Related]
11. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of postoperative morbidities in patients with advanced epithelial ovarian cancer treated with neoadjuvant chemotherapy and delayed primary surgical debulking.
Le T; Alshaikh G; Hopkins L; Faught W; Fung MF
Ann Surg Oncol; 2006 Dec; 13(12):1711-6. PubMed ID: 17009146
[TBL] [Abstract][Full Text] [Related]
13. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
Silva EG; Gershenson DM; Malpica A; Deavers M
Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
[TBL] [Abstract][Full Text] [Related]
14. [Recurrence risk factors of platinum-sensitive epithelial ovarian cancer].
Yan XJ; Liang LZ; Zeng ZY; Liu JH; Yuan SH; Wei M
Ai Zheng; 2005 Jun; 24(6):751-4. PubMed ID: 15946495
[TBL] [Abstract][Full Text] [Related]
15. Histological classification of ovarian cancer.
Kaku T; Ogawa S; Kawano Y; Ohishi Y; Kobayashi H; Hirakawa T; Nakano H
Med Electron Microsc; 2003 Mar; 36(1):9-17. PubMed ID: 12658347
[TBL] [Abstract][Full Text] [Related]
16. [MR Imaging of primary ovarian tumors with pathologic correlation].
Bouic-Pagès E; Perrochia H; Mérigeaud S; Giacalone PY; Taourel P
J Radiol; 2009; 90(7-8 Pt 1):787-802. PubMed ID: 19752784
[TBL] [Abstract][Full Text] [Related]
17. [Ovarian tumors of low malignant potential (borderline ovarian tumors)].
Luchian AM; Pricop M
Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):438-45. PubMed ID: 21870737
[TBL] [Abstract][Full Text] [Related]
18. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.
Bristow RE; Montz FJ; Lagasse LD; Leuchter RS; Karlan BY
Gynecol Oncol; 1999 Mar; 72(3):278-87. PubMed ID: 10053096
[TBL] [Abstract][Full Text] [Related]
19. [Endometrioid adenocarcinoma of the uterine cervix associated with mucinous ovarian cystadenocarcinoma].
Ferchichi L; Rammeh-Rommani S; Ben Hammouda S; Sfar R; Farah F; Ben Jilani S; Zermani R
Gynecol Obstet Fertil; 2006 May; 34(5):410-2. PubMed ID: 16677843
[TBL] [Abstract][Full Text] [Related]
20. Initial chemotherapy followed by surgical cytoreduction for the treatment of stage III/IV epithelial ovarian cancer.
Everett EN; French AE; Stone RL; Pastore LM; Jazaeri AA; Andersen WA; Taylor PT
Am J Obstet Gynecol; 2006 Aug; 195(2):568-74; discussion 574-6. PubMed ID: 16890558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
